EMY-25275-90962
2 vaccinations
2 coded responses
7 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 220 / VA
- Registered
- 2022-06-27
- Relationship
- Child or adolescent in my care
- Guardian
- K7U-22355-44610
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-23
Dose 1 — Pfizer-BioNTech
-
2022-06-27
Registered in v-safe
- 2022-06-28
- 2022-06-29
- 2022-06-30
-
2022-07-09
Survey response — day 14, dose 1, under 3MedDRA: Pyrexia, Vomiting — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fever and vomitingMedDRA releases: 2024-11 · check-in free text available
-
2022-07-27
Dose 2 — Pfizer-BioNTech
- 2022-07-30
-
2022-08-01
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
-
2022-08-12
Survey response — day 14, dose 2, under 3MedDRA: Body temperature increased — Feeling: GoodFree text: Fever low grade 100MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-23 | Pfizer-BioNTech | No |
| 2 | 2022-07-27 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Fever and vomiting
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Fever low grade 100
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Body temperature increased | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release